¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå
Male Urinary Incontinence
»óǰÄÚµå : 1791904
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 563 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,257,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,771,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀåÀº 2030³â±îÁö 92¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 69¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ³²¼º ¿ä½Ç±Ý ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 4.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 92¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³²¼º ¿ä½Ç±Ý ºñÈí¼öÁ¦´Â º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀ̸ç, CAGRÀº 5.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 60¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³²¼º ¿ä½Ç±Ý Èí¼öÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 3.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯, Áß±¹Àº CAGR 8.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 19¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.9%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.9%¿Í 3.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ³²¼º ¿ä½Ç±Ý ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³²¼º ¿ä½Ç±ÝÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

³²¼º ¿ä½Ç±Ý(UI)Àº ƯÈ÷ °í·ÉÈ­ »çȸ, Àü¸³¼± ¼ö¼úÀ̳ª ¹æ»ç¼± Ä¡·á¸¦ ¹ÞÀº ³²¼º, ½Å°æÁúȯÀ» ¾Î°í ÀÖ´Â ³²¼ºµé »çÀÌ¿¡¼­ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. UI´Â »îÀÇ Áú¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡¸ç, ½ÅüÀû ºÒÆíÇÔ, Á¤½ÅÀû °íÅë, »çȸÀû ¼öÄ¡½ÉÀ» °¡Á®¿É´Ï´Ù. ºñħ½ÀÀû ¹× ¼ö¼úÀû Ä¡·á¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ºñħ½ÀÀû ¹× ¿Ü°úÀû °³ÀÔÀÇ ¹ßÀüÀÌ ³²¼º ¿ä½Ç±Ý ¼Ö·ç¼Ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Èí¼ö ÆÐµå, ¿ÜºÎ ¿äµµ ÀåÄ¡, °ñ¹ÝÀú ¿ä¹ý, ¼ö¼ú¿ë ÀÓÇöõÆ® µî È¿°úÀûÀÌ°í ´«¿¡ ¶çÁö ¾Ê´Â °ü¸® ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â Ä¡·á¸¦ ¿øÇÏ´Â ³²¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¶Àý½Ä ¿ä°ý¾à±Ù, »ýü°øÇÐ ÀÓÇöõÆ®, ½Å°æÀڱؿä¹ý µîÀÇ ±â¼ú Çõ½Åµµ ¿ä½Ç±Ý ¼Ö·ç¼ÇÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾î¶»°Ô ³²¼º ¿ä½Ç±Ý Ä¡·áÀÇ ¼º´ÉÀ» Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀº UI Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À Çǵå¹é ¹× AI ±â¹Ý °¡À̵带 °®Ãá ½º¸¶Æ® ¿þ¾î·¯ºí °ñ¹ÝÀú Ä¡·á ÀåÄ¡´Â ³²¼ºÀÌ ¼ö¼ú ¾øÀÌ ¹æ±¤À» Á¶ÀýÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¾Ð½Ä °ý¾à±Ù ÀÓÇöõÆ®¿Í »ýüÀûÇÕ¼º ½½¸µÀº ¼ö¼ú ȯÀÚÀÇ Æí¾ÈÇÔ°ú Àå±âÀûÀÎ È¿°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù.

½Å°æ ½ÅÈ£¸¦ ÀÚ±ØÇÏ¿© ¹æ±¤ Á¶ÀýÀ» °³¼±ÇÏ´Â ºñħ½ÀÀû ½Å°æÁ¶Àý ±â¼úÀÇ °³¹ßµµ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¿ä½Ç±Ý °ü¸® ±â±¸¿Í Àç»ç¿ëÀÌ °¡´ÉÇϰí ģȯ°æÀûÀÎ Èí¼ö Á¦Ç°Àº ³²¼º ¿ä½Ç±Ý °ü¸®ÀÇ ÆíÀǼº°ú Áö¼Ó°¡´É¼ºÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

Àü¸³¼± ÀýÁ¦¼ú ÈÄ ¿ä½Ç±Ý(PPI), ºñ¸¸°ú °ü·ÃµÈ ¿ä½Ç±Ý, ´ç´¢º´À¸·Î ÀÎÇÑ ¹æ±¤ ±â´É Àå¾ÖÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì¿Í À¯·´Àº Àα¸ °í·ÉÈ­·Î ÀÎÇØ 60¼¼ ÀÌ»ó ³²¼ºÀÇ ¿ä½Ç±Ý ¹ß»ý·üÀÌ ³ô¾ÆÁö¸é¼­ ¿ä½Ç±Ý ¼Ö·ç¼ÇÀÇ Ã¤Å÷üÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ¿ø°Ý ÀǷḦ ÅëÇÑ Áø·á°¡ Áõ°¡Çϸ鼭 ³²¼ºµéÀÌ ³«ÀÎ ÂïÈ÷Áö ¾Ê°í ½±°Ô Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. º¸Çè»ç ¹× Á¤ºÎ ÀÇ·á ÇÁ·Î±×·¥µµ °í±Þ UI Ä¡·á¿¡ ´ëÇÑ È¯±Þ ¹üÀ§¸¦ È®´ëÇϰí ÀÖÀ¸¸ç, ÀÚ°¡ °ü¸® ¼Ö·ç¼Çº¸´Ù ÀÇ·á °³ÀÔÀ» ¿øÇϴ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³²¼º Àü¹® À£´Ï½º Ŭ¸®´Ð°ú ºñ´¢±â°ú Àü¹® Ä¡·á ¼¾ÅÍÀÇ Á¸Àç°¨ÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ç°­°ú Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» ¿ì¼±½ÃÇÏ´Â ³²¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´«¿¡ ¶çÁö ¾Ê°í Æí¾ÈÇϸç È¿°úÀûÀÎ ¿ä½Ç±Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°úÁ¦¿Í ¹Ì·¡ ±âȸ´Â?

³²¼ºÀÇ Á¶±â ÀÇ·á °³ÀÔÀ» ¹æÇØÇÏ´Â ÀÎ½Ä ºÎÁ·°ú »çȸÀû ³«ÀÎ µîÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼úÀû Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ƯÁ¤ Áö¿ª¿¡¼­ÀÇ Á¦ÇÑµÈ º¸Çè Àû¿ë ¹üÀ§°¡ º¸±Þ¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª AI¸¦ Ȱ¿ëÇÑ ¹ÙÀÌ¿ÀÇǵå¹é Ä¡·á, ·Îº¿À» ÀÌ¿ëÇÑ ¿ä½Ç±Ý ¼ö¼ú, Àúħ½ÀÀû ½Å°æÁ¶Àý ±â¼ú µîÀÌ ºÎ»óÇϰí ÀÖ¾î ÇâÈÄ ¼ºÀå ±âȸ°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Àú·ÅÇÑ Ä¡·á ¿É¼ÇÀÌ ÀÖ´Â ½ÅÈï±¹ ½ÃÀåÀ¸·ÎÀÇ ÁøÃâÀº ¾÷°èÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(³²¼º ¿ä½Ç±ÝºñÈí¼öÁ¦, ³²¼º ¿ä½Ç±Ý Èí¼öÁ¦);¿ä½Ç±Ý(½ºÆ®·¹½º¼º ¿ä½Ç±Ý, Àý¹Ú¼º ¿ä½Ç±Ý, °ú·ù¼º ¿ä½Ç±Ý, ±â´É¼º ¿ä½Ç±Ý, È¥ÇÕ¼º ¿ä½Ç±Ý);À¯Åë ä³Î(¿ÀÇÁ¶óÀÎ Á¡Æ÷ À¯Åë ä³Î, ¿Â¶óÀÎ À¯Åë ä³Î);¿ëµµ(ÀçÀÌ¿ë °¡´É ¿ëµµ, ÀÏȸ¿ë ¿ëµµ);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ¹× Áø·á¼Ò ÃÖÁ¾»ç¿ëÀÚ, ȨÄɾî ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Male Urinary Incontinence Market to Reach US$9.2 Billion by 2030

The global market for Male Urinary Incontinence estimated at US$6.9 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Male Urinary Incontinence Non-Absorbent, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$6.0 Billion by the end of the analysis period. Growth in the Male Urinary Incontinence Absorbents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 8.9% CAGR

The Male Urinary Incontinence market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Male Urinary Incontinence Market - Key Trends & Drivers Summarized

Why Is Male Urinary Incontinence Gaining Importance?

Male urinary incontinence (UI) is a growing health concern, particularly among aging populations and men who have undergone prostate surgery, radiation therapy, or suffer from neurological conditions. It significantly impacts quality of life, leading to physical discomfort, emotional distress, and social embarrassment. The increasing awareness of available treatments and advancements in non-invasive and surgical interventions are driving the market for male urinary incontinence solutions.

The demand for effective and discreet management options, including absorbent pads, external urinary collection devices, pelvic floor therapy, and surgical implants, is increasing as more men seek medical treatment. Innovations in adjustable urinary sphincters, bioengineered implants, and neurostimulation therapies are also contributing to the expanding landscape of urinary incontinence solutions.

How Are Innovations Enhancing the Performance of Male Urinary Incontinence Treatments?

Technology is playing a vital role in improving UI treatment outcomes. Smart wearable pelvic floor therapy devices equipped with biofeedback and AI-driven guidance are helping men regain bladder control without surgery. Additionally, hydraulic sphincter implants and biocompatible slings are improving comfort and long-term efficacy for surgical patients.

The development of non-invasive neuromodulation techniques, which stimulate nerve signals to improve bladder control, is also gaining traction. Custom-fitted urinary incontinence management devices and reusable, eco-friendly absorbent products are further enhancing convenience and sustainability in male UI care.

What Are the Key Market Drivers?

The increasing prevalence of post-prostatectomy incontinence (PPI), obesity-related UI, and diabetes-induced bladder dysfunction is fueling market growth. Aging demographics, particularly in North America and Europe, are leading to higher adoption rates of urinary incontinence solutions, as men over 60 are more likely to experience UI.

Additionally, greater healthcare accessibility and the rise of telemedicine consultations are making it easier for men to seek treatment without stigma. Insurance companies and government healthcare programs are also expanding reimbursement coverage for advanced UI treatments, driving more patients toward medical intervention rather than self-managed solutions.

The growing presence of male-specific wellness clinics and specialized urology treatment centers is further contributing to market expansion. As more men prioritize health and active lifestyles, the demand for discreet, comfortable, and effective urinary incontinence treatments continues to rise.

What Challenges and Future Opportunities Exist?

Challenges include lack of awareness and social stigma preventing men from seeking early medical intervention. Additionally, high costs associated with surgical treatments and limited reimbursement coverage in certain regions hinder adoption. However, emerging AI-powered biofeedback therapy, robotic-assisted incontinence surgeries, and minimally invasive neuromodulation techniques present future growth opportunities. Expansion into developing markets with affordable treatment options could further drive industry growth.

SCOPE OF STUDY:

The report analyzes the Male Urinary Incontinence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Male Urinary Incontinence Non-Absorbent, Male Urinary Incontinence Absorbents); Incontinence (Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Incontinence, Functional Urinary Incontinence, Mixed Urinary Incontinence); Distribution Channel (Offline Stores Distribution Channel, Online Distribution Channels); Usage (Reusable Usage, Disposable Usage); End-Use (Hospitals & Clinics End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â